Watson Pharmaceuticals Inc Sample Contracts

AutoNDA by SimpleDocs
ARTICLE 1 AMENDMENTS
Credit Agreement • March 16th, 1998 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • California
1 EXHIBIT 99.1 AGREEMENT AND PLAN OF MERGER AMONG WATSON PHARMACEUTICALS, INC. WS ACQUISITION CORP.
Agreement and Plan of Merger • May 31st, 2000 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Recitals: --------
Lease Agreement • March 31st, 1999 • Watson Pharmaceuticals Inc • Pharmaceutical preparations
Exhibit 10.15 AMENDED AND RESTATED CREDIT AGREEMENT Dated as of August 28, 2000
Credit Agreement • March 30th, 2001 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • New York
1 EXHIBIT 10.1 CREDIT AGREEMENT Dated as of July 5, 2000
Credit Agreement • July 14th, 2000 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • New York
RECITALS
Lease • November 13th, 1995 • Watson Pharmaceuticals Inc • Medicinal chemicals & botanical products
SUPPLY AGREEMENT ----------------
Supply Agreement • December 3rd, 1998 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • Illinois
WITNESSETH ----------
Distribution Agreement • March 30th, 2001 • Watson Pharmaceuticals Inc • Pharmaceutical preparations
RECITALS
Watson Pharmaceuticals Inc • March 31st, 1997 • Pharmaceutical preparations
RECITALS
Business Loan Agreement • March 31st, 1997 • Watson Pharmaceuticals Inc • Pharmaceutical preparations
AND
Credit Agreement • March 16th, 1998 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • California
ARTICLE 1 AMENDMENT
Credit Agreement • March 30th, 2000 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • California
EXHIBIT 10.20(B) AMENDMENT TO STOCK OPTION AGREEMENT
Stock Option Agreement • March 16th, 1998 • Watson Pharmaceuticals Inc • Pharmaceutical preparations
Agreement ---------
Stock Option Agreement • January 21st, 1999 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
AMONG
Asset Purchase Agreement • October 31st, 1997 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • Illinois
AutoNDA by SimpleDocs
WATSON PHARMACEUTICALS, INC. 10,537,755 Shares of Common Stock Underwriting Agreement
Watson Pharmaceuticals Inc • November 17th, 2010 • Pharmaceutical preparations • New York

Quiver Inc., a British Virgin Islands limited liability company and a stockholder (the “Selling Stockholder”) of Watson Pharmaceuticals, Inc., a Nevada corporation (the “Company”), proposes to sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representative (the “Representative”), 10,537,755 shares of common stock, par value $0.0033 per share, of the Company (the “Shares”). To the extent there are no additional Underwriters listed on Schedule 1 hereto other than you, the term Representative as used herein shall mean you, as Underwriter, and the term Underwriters shall mean either the singular or plural as the context requires. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

RECITAL:
Consulting Agreement • March 16th, 1998 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • Florida
CREDIT AGREEMENT WATSON PHARMACEUTICALS, INC. and MELLON BANK, N.A. February 3, 1999
Credit Agreement • March 31st, 1999 • Watson Pharmaceuticals Inc • Pharmaceutical preparations • California
Recitals: --------
Watson Pharmaceuticals Inc • March 30th, 2001 • Pharmaceutical preparations
1 Exhibit 1.1 WATSON PHARMACEUTICALS, INC. 7 1/8% SENIOR NOTES DUE 2008 UNDERWRITING AGREEMENT
Watson Pharmaceuticals Inc • May 18th, 1998 • Pharmaceutical preparations • New York
EXHIBIT 10.3 __________, 19__
Watson Pharmaceuticals Inc • November 25th, 1998 • Pharmaceutical preparations
Time is Money Join Law Insider Premium to draft better contracts faster.